Hà Ritaskrá 2006 - Háskóli Ãslands
Hà Ritaskrá 2006 - Háskóli Ãslands
Hà Ritaskrá 2006 - Háskóli Ãslands
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Nýjungar í barnalækningum – Unglæknadagurinn, 18. febrúar<br />
<strong>2006</strong>.<br />
Eyrnabólgur og ónæmiskerfið. Málþing um miðeyrnabólgur á<br />
vegum háls-, nef- og eyrnalækninga læknadeildar Háskóla<br />
Íslands. Des <strong>2006</strong>.<br />
Erfðafræði<br />
Jórunn E. Eyfjörð prófessor<br />
Greinar í ritrýndum fræðiritum<br />
Population-Based Study of Changing Breast Cancer Risk in<br />
Icelandic BRCA2 Mutation Carriers, 1920–2000. J Natl<br />
Cancer Inst; 98: 116-122 (<strong>2006</strong>). Laufey Tryggvadottir, Helgi<br />
Sigvaldason, Gudridur H. Olafsdottir, Jon G. Jonasson,<br />
Thorvaldur Jonsson, Hrafn Tulinius, Jorunn E. Eyfjörd.<br />
Clinical value of somatic TP53 gene mutations in 1794 breast<br />
cancer patients. Clin Ca Res, 12, 1157-1167 (<strong>2006</strong>). Magali<br />
Olivier, Anita Langerød, Patrizia Carrieri, Jonas Bergh,<br />
Sigrid Klaar, Jorunn Eyfjord, Charles Theillet, Carmen<br />
Rodriguez, Rosette Lidereau, Ivan Bièche, Jennifer Varley,<br />
Yves Bignon, Nancy Uhrhammer, Robert Winqvist, Arja<br />
Jukkola-Vuorinen, Dieter Niederacher, Shunsuke Kato,<br />
Chikashi Ishioka, Pierre Hainaut, Anne-Lise Børresen-<br />
Dale.<br />
Epigenetic silencing and deletion of the BRCA1 gene in sporadic<br />
breast cancer. Breast Cancer Res. Jul 17;8(4):R38 (<strong>2006</strong>).<br />
Valgerdur Birgisdottir, Olafur A Stefansson, Sigridur K<br />
Bodvarsdottir, Holmfridur Hilmarsdottir, Jon G Jonasson,<br />
Jorunn E Eyfjord. Greinin var sérstaklega “higlighted” á<br />
vefsíðu Breast Cancer Res fyrir júlímánuð <strong>2006</strong>.<br />
Aurora-A amplification associated with BRCA2 mutation in<br />
breast tumours. Cancer Lett. Jul 21; [Epub ahead of print]<br />
(<strong>2006</strong>). Sigridur K. Bodvarsdottir, Margret Steinarsdottir,<br />
Valgerdur Birgisdottir, Holmfridur Hilmarsdottir, Jon G.<br />
Jonasson, Jorunn E. Eyfjord.<br />
Positive association between plasma antioxidant capacity and<br />
n-3 PUFA in red blood cells from Icelandic women. Lipids<br />
41 (2): 119-125 Feb (<strong>2006</strong>). Thorlaksdottir AY, Skuladottir GV,<br />
Petursdottir AL, Tryggvadottir L, Ogmundsdottir HM,<br />
Eyfjord JE, Jonsson JJ, Hardardottir I.<br />
Breast cancer risk associated with Aurora-A 91T->A<br />
polymorphism in relation to BRCA2 mutation. Cancer Lett<br />
<strong>2006</strong> Nov 16; [Epub ahead of print] (<strong>2006</strong>). Linda<br />
Vidarsdottir Sigridur K. Bodvarsdottir, Holmfridur<br />
Hilmarsdottir, Laufey Tryggvadottir, Jorunn E. Eyfjord.<br />
Fyrirlestrar<br />
Gestafyrirlestur: BRCA genes in an Island Population.<br />
Innovations in Research: Implications for Health Services<br />
and Policy. Jórunn Erla Eyfjörð. St. John´s, Newfoundland.<br />
Oct 19, <strong>2006</strong>. Plenary. Þátttaka í pallborðsumræðum sama<br />
dag og fundum með rannsóknahópum 20. október.<br />
NLCAHR http://www.nlcahr.mun.ca/.<br />
Prostate cancer survival in BRCA2 mutation carriers. Jórunn<br />
Erla Eyfjörd. IMPACT steering committee meeting, London,<br />
17. mars <strong>2006</strong><br />
IMPACT Identification of Men with genetic predisposition to<br />
Prostate Cancer: Targeted Screening in BRCA1/2 mutation<br />
carriers and non-carriers. Survival in BRCA2 prostate<br />
cancer cases. Ráðstefna í Szczecin, Póllandi, 28.-30.<br />
nóvember <strong>2006</strong>. Jórunn E. Eyfjörd.<br />
Veggspjald<br />
Formation of Rad51foci in breast epithelial cell lines carrying a<br />
BRCA2 mutation. EACR meeting, Búdapest, Ungverjalandi,<br />
1.-4. júlí <strong>2006</strong>. Jenny B. Thorsteinsdottir, Gardar Myrdal,<br />
Jorunn E. Eyfjörd & Helga M. Ögmundsdottir.<br />
Frumulíffræði<br />
Helga M. Ögmundsdóttir prófessor<br />
Greinar í ritrýndum fræðiritum<br />
Establishment of three human breast epithelial cell lines<br />
derived from carriers of the 999del5 BRCA2 Icelandic<br />
founder mutation. In Vitro Cell Dev Biol Anim. 2005. 41:337-<br />
342. Fridriksdottir AJR, Gudjonsson Th, Halldorsson Th,<br />
Björnsson J, Steinarsdottir M, Johannsson OTh,<br />
Ögmundsdottir HM.<br />
Effect of hypoxia and TP53 mutation status on culture and<br />
cytogenetics of normal and malignant mammary<br />
epithelium. Cancer Genet Cytogenet <strong>2006</strong>. 165:144-<br />
150.Vidarsson H, Steinarsdóttir M, Jónasson JG ,<br />
Júlíusdóttir H, Hauksdóttir H , Hilmarsdóttir H,<br />
Halldórsdóttir K, Ögmundsdóttir HM.<br />
Evidence for extrathymic T-cell maturation after thymectomy in<br />
infancy. Clin Exp Immunol <strong>2006</strong>. 145: 407-412. Torfadottir H,<br />
Freysdottir J, Skaftadottir I, Haraldsson A, Sigfusson G,<br />
Ögmundsdottir HM.<br />
Positive association between plasma antioxidant capacity and<br />
n-3 PUFA in red blood cells from Icelandic women. Lipids<br />
<strong>2006</strong>. 41: 119-125. Thorlaksdottir AY, Skuladottir GV,<br />
Petursdottir AL, Tryggvadottir L, Ogmundsdottir HM,<br />
Eyfjord JE, Jonsson JJ, Hardardottir I.<br />
Human breast endothelial cells retain their phenotypic traits of<br />
origin after prolonged culture in vitro. In Vitro Cell Dev Biol<br />
Anim <strong>2006</strong>. 42:332-340. Sigurdsson V, Fridriksdottir AJ,<br />
Kjartansson J, Jonasson JG, Steinarsdottir M,<br />
Ogmundsdottir HM, Gudjonsson T.<br />
Fyrirlestur<br />
Therapeutic vaccines against cancer. Helga M. Ögmundsdóttir.<br />
Nordic Vaccine Meeting, Reykjavík. Pre-Conference<br />
Symposium, 24. ágúst <strong>2006</strong>.<br />
Veggspjöld<br />
Monoclonal gammopathy: Natural history studied with a<br />
retrospective approach. 11th Congress of the European<br />
Hematology Association, Amsterdam, Hollandi, 15.-18. júní<br />
<strong>2006</strong>. Hlín Steingrímsdóttir, Vilhelmína Haraldsdóttir,<br />
Vilmundur Guðnason, Ísleifur Ólafsson, Helga M.<br />
Ögmundsdóttir.<br />
Formation of Rad51 foci in breast epithelial cell lines carrying a<br />
BRCA2 mutation. 19th Meeting of the European Association<br />
for Cancer Research, Búdapest, Ungverjalandi, 1.-4. júlí<br />
<strong>2006</strong>. Jenný Björk Þorsteinsdóttir, Garðar Mýrdal, Jórunn<br />
Erla Eyfjörð, Helga M. Ögmundsdóttir.<br />
Usnic acid: anti-proliferative, apoptotic and morphological<br />
effects on human malignant cell lines. Guðleif Harðardóttir,<br />
Helga M. Ögmundsdóttir, Kristín Ingólfsdóttir. 54th Annual<br />
Congress on Medicinal Plant Research, Helsinki, Finnlandi,<br />
29. ágúst-2. september,<strong>2006</strong>.<br />
Fræðsluefni<br />
Svar á vísindavefnum: Er túmorsjúkdómurinn í Mýrinni eftir<br />
Arnald Indriðason til í alvörunni? Birt 15.5.<strong>2006</strong>.<br />
Þórarinn Guðjónsson sérfræðingur<br />
Greinar í ritrýndum fræðiritum<br />
Gudjonsson, T., Adriance, M.C., Sternlicht, M.D., Petersen, O.W.,<br />
and Bissell, M.J. (<strong>2006</strong>). Myoepithelial cells: Their origin<br />
and function in breast morphogenesis and neoplasia. J<br />
Mammary Gland Biol Neoplasia. 10(3): 261-72.<br />
Asgrimsson, V., Gudjonsson, T., Gudmundsson, G.H., and<br />
Baldursson, O. (2005).The macrolide antibiotic<br />
83